Bioventus (BVS) Change in Receivables (2020 - 2026)

Bioventus' Change in Receivables history runs 7 years deep, the most recent figure standing at -$7.3 million for Q1 2026.

• Quarterly Change in Receivables rose 18.73% year-over-year to -$7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 979.05% YoY) and the FY2025 annual result came in at $916000.0, down 91.41% from the prior year.
• Change in Receivables was -$7.3 million for Q1 2026 at Bioventus, down from -$1.9 million in the prior quarter.
• Across five years, Change in Receivables topped out at $25.6 million in Q3 2022 and bottomed at -$17.1 million in Q3 2024.
• A 5-year average of $698882.4 and a median of -$1.8 million in 2025 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2024 — Change in Receivables soared 989.74% — and 2025, when it plunged 559.86%.
• Bioventus' Change in Receivables stood at $4.8 million in 2022, then surged by 90.23% to $9.2 million in 2023, then sank by 36.99% to $5.8 million in 2024, then plunged by 132.54% to -$1.9 million in 2025, then tumbled by 288.22% to -$7.3 million in 2026.
• Business Quant data shows BVS's Change in Receivables at -$7.3 million in Q1 2026, -$1.9 million in Q4 2025, and -$1.8 million in Q3 2025.